摘要 |
The invention provides a compound of formula (I): [Chemical formula should be inserted here. Please see paper copy.] wherein R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>3a</SUB>, R<SUB>4</SUB>, R<SUB>4a</SUB>, R<SUB>5</SUB>, and R<SUB>6 </SUB>are as defined; or a pharmaceutically acceptable salt thereof or a solvate thereof; compositions containing these compounds, processes for preparing them and their use as modulators of chemokine activity (especially CCR5 activity). |